SHYCOCAN – THE ULTIMATE COUNTER-MECHANISM TO DISABLE THE CORONA FAMILY OF VIRUSES. THE SHYCOCAN BRINGS INNOVATIVE AND GROUNDBREAKING TECHNOLOGY TO PROMOTE TRANSMISSION JAMMING MECHANISMS IN AN EFFICIENT AND COST-EFFECTIVE MANNER FOR GREATER ACCESSIBILITY ACROSS COMMUNITIES WORLDWIDE.
Scalene Hypercharge Corona Canon (SHYCOCAN) emits trillions of photons per second creating negatively charged electron cloud across closed spaces. The emanated electrons are proven to be able to attach to negative seeking s-protein and hence results in disarming the s-protein.
The secondary mode of working being based on Malter Effect; when particles such as a virus, a non or a poor conductor consisting of protein like structures, is applied to the active component of the canon, which is excited to high potential at a high frequency and is subjected to photon bombardment, results in secondary electron emission. Hence the Malter Effect that occurs with the participation of the viral and other particles in the contaminated air plays a secondary mode in its containment.
ULTIMATELY, IT IS PROVEN TO BE EFFECTIVE IN THE DEBILIATION OF 99.9% OF CORONA FAMILY OF VIRUSES, PROVIDING OUR CLIENTS WITH THE NECESSARY PEACE OF MIND WITH REAL-TIME AIRBORNE PROTECTION USING STATE OF THE ART TECHNOLOGY.
The application of SHYCOCAN is endless, including placements within educational and health facilities, schools and hospitals, aged-care facilities, corporate and commercial settings, dining and social venues, fitness and wellbeing centers, workplaces and more.
HOW DOES CORONAVIRUS SPREAD?
Rapid, close quarters and effective host initiation are all synonymous to the way Coronavirus spreads. The invisible virus can effortlessly spread between people, especially indoors and poorly ventilated spaces. As soon as an infected person coughs, sneezes or even speaks, up to millions of invisible virus particles are released into the surroundings via respiratory droplets, where they can remain infectious for approximately 14-28 days or more. Whilst the greater droplets land on all nearby surfaces, micro-droplets can remain suspended airborne for up to 20 minutes, or up to 48 hours on surfaces indoors.
Coronavirus virions are sphere-like with
diameters of approximately 125 nm, which
has been determined by the utilisation of
cryo‐electron tomography and cryo‐electron
microscopy. These spherical virions consist of
Spike Protein, covering the outer surface.
When exposed, the virus uses Spike Proteins
to enter host cells and initiate replication
The outer spikes securely attach themselves to the negatively charged walls of a host cell, resulting
in the formation of a path that allows the virus to enter the host cell and completely infect it in a
rapid amount of time.
HOW TO STOP THE SPREAD?
Research and extensive knowledge to contain Corona virus lies in disabling and debilitating the connection of this bridge. Probably, the only way to eradicate the spread of this active virus is physically diminishing or disarming the S-Protein so that the virus cannot attach to the human cell receptor.
THIS DEVICE HAS BEEN REGULATORY APPROVED UNDER A PLETHORA OF STANDARDS AND IS MOST EFFECTIVE IN CLOSED AND CONFINED SPACES OF DAILY LIFE AND WORK. THIS WAY, THE GROUNDBREAKING TECHNOLOGY BEHIND THE SHYCOCAN CAN GET THE COMMUNITY BACK ON ITS FEET AND HEADING IN THE RIGHT DIRECTION FOR A SUSTAINABLE AND STRONG FUTURE.
Check out the full list of Regulatory Compliance testing completed for Shycocan by clicking here
The device complies to all the applicable International Regulatory standards, relating to safety,
EMI/EMC and Efficacy.
- 2014/30/EU ‐ Electromagnetic Compatibility Directive
- 2014/30/EU ‐ Low Voltage Directive
- IEC 60335‐1:2010, CORJ :2010, COR2:201 l, AMO1:2013, CORJ:2014, AMD2:2016, CORJ:2016
- IEC 61326‐1:2012
- Ozone Safety Test Study; Report No. Shy-OZ-05072020, Test No: SHY-2306-50-1 :: Ozone levels were below detection levels (BDL) during an 8 hours tested in a closed chamber. Requirement: US EPA, FDA, EUA.
- Ozone Safety with temperature and humidity validation study; EVA ref. M3646 – Australian regulatory requirement.
- Virology Study; Laboratories de Especialidades Immunological S.A. de C.V, Report No: 44527- Viricidal Activity (Equine arteritis virus, ATCC VR-796, enveloped RNA virus) concludes 99.9% virus elimination, dated June 16, 2020.
- Capsid Study (S-Protein); Virucidal activity. The interpretation of the result is that within the exposure times tested the equipment SHYCOCAN eliminates the infectivity of inﬂuenza B corona virus in near magnitudes of the exhaled virus by a symptomatic seasonal inﬂuenza B virus infected patient for 30 minutes. (report no. 44527- virucidal activity (inﬂuenza B) for SHYCOCAN device LdeEI. SA. De CV)
- Surface decontamination study; MS2 phage ATCC 15597B1; Reduction; (MS2 phage;12ft;1hour; count before treatment 9×106 pfu/swab; count after treatment 4.8×102 pfu/swab; percentage reduction 99.994%)
- Proven to be harmless to bacteria, fungi, plants, and animals.
- CE Mark with Class I Classification
- SHYCOCAN is currently market-enabled as per the U.S. FDA’s Enforcement Discretion Guidance during the COVID-19 Public Health Emergency.
- Australian TGA has considered this device as an excluded goods under Therapeutic Goods (excluded Goods) Determination 2018, schedule I, item 12 – Environmental Control / Detoxiﬁcation Equipment.
- DGHS-CDSCO, India: Class A device: Registration No: MFG/MD/2020/27975.
- MEDSAFE, considers Shycocan as not falling into the deﬁnition of a medical device in New Zealand Hence by proper labeling norms and ensuring it’s safe and eﬀectiveness and compliance with Fair Trading Act 1996 and Consumer Guarantee Act 1993, the device may be made available in New Zealand
SCALENE HYPERCHARGE CORONA CANON -SHYCOCAN IS A VERY PRACTICAL AND COMPLIMENTARY SOLUTION – ALONG WITH THE USE OF PERSONAL PROTECTIVE EQUIPMENT (PPE), AND OTHER MANDATED NORMS OF BREAKING THE CHAIN OF COVID19.
DISABLE. PROTECT. PREVENT
The device Scalene Hypercharge Corona Canon (SHYCOCAN), is expertly engineered to protect individuals from the spread of the Corona family of viruses whilst also utilising containment technology. There is an urgent need for a simple, portable, user-friendly and sensitive methodology to prevent mass outbreaks with additional spreading of COVID-19. With 43 million people infected and counting, we are actively combating the deadly virus and our product plays a pivotal role in healthcare as the finest preventative maintenance device for Coronavirus.